Merck CEO Kenneth Frazier is sticking around. The New Jersey-based pharmaceutical giant said Wednesday that its board of directors had overturned a policy requiring CEOs to retire when they turn ...
Frazier stepped down as Merck CEO in February 2021 after nearly 30 years at the pharma group, including 10 years in the top job during which time he is credited with overseeing the fast ...
During an hour-long, wide-ranging interview with the Economic Club of New York, Frazier, the CEO of New Jersey-based pharma giant Merck, addressed the issue of rising prescription drug costs and ...
Merck CEO Robert Davis joins 'Squawk Box' to discuss the company's quarterly earnings results, which topped expectations as the company saw strong sales from its top-selling cancer drug Keytruda ...
Merck Foundation, conducted the 11th Edition of their annual conference, "Merck Foundation Africa Asia Luminary".
The healthcare industry came together Wednesday to share thoughts on and reactions to the death of UnitedHealthcare CEO Brian ...
Merck reported good news Tuesday on a more convenient version of its cancer drug Keytruda, a reassuring sign following ...
Eight months after snaring an inaugural FDA green light, Merck & Co. is bolstering the case for the chief asset in its $11.5 ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, has ranked No. 1 on Newsweek’s annual list of America’s Most Responsible Companies for the second year in a row.
Cambridge-based Abselion, an innovator in automated analytical instrumentation that simplifies at-line protein quantification ...